The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 27, 2023
Filed:
Oct. 05, 2017
Applicant:
Board of Regents, the University of Texas System, Austin, TX (US);
Inventors:
Assignee:
Board of Regents, The University of Texas System, Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2019.01); A61K 38/17 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); C07K 14/47 (2006.01); C07K 16/28 (2006.01); C12N 5/0783 (2010.01); C07K 7/06 (2006.01); A61K 38/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 38/08 (2013.01); A61K 38/1709 (2013.01); A61P 37/04 (2018.01); C07K 14/4748 (2013.01); C07K 16/2818 (2013.01); C12N 5/0638 (2013.01); A61K 38/00 (2013.01); A61K 45/06 (2013.01); C07K 7/06 (2013.01); C12N 2501/60 (2013.01); C12N 2502/1121 (2013.01);
Abstract
Provided herein are tumor-antigen VGLL1 specific peptides. Also provided herein are methods of generating VGLL1-specific T cells and their use for the treatment of cancer. In addition, the VGLL1-specific peptides may be used as a vaccine.